Institutional investors hold a majority ownership of CELG through the 82.76% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
FIDELITY MANAGEMENT & RESEARCH C... Bought 3.5 Million shares of Celgene
THE VANGUARD GROUP, INC. Bought 1.8 Million shares of Celgene
JPMORGAN INVESTMENT MANAGEMENT, ... Bought 1.4 Million shares of Celgene